Skip to Main Content

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot?

Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the ongoing layoffs. Despite the downsizing, there is movement. Here are some of the latest comings and goings. Recognize anyone?

And here is our regular feature in which we highlight a different person each week. This time around, we note that Array BioPharma hired Jason Haddock as chief financial officer. Most recently, he was chief financial officer and chief operating officer at Berg Health. Before that, he worked at Bristol-Myers Squibb and Mead Johnson Nutritionals.

advertisement

Bristol-Myers Squibb named Dr. Fouad Namouni as oncology development head;

Molecular Health hired Gerry Sheridan as chief financial officer;

advertisement

Molecular Health hired Dr. Les Paul as chief medical officer;

VBI Vaccines hired Dr. Francisco Diaz-Mitoma as chief medical officer;

Aceto hired Walter Kaczmarek III as chief operating officer;

Oramed Pharmaceuticals hired Dr. Roy Eldor as chief medical officer;

Gradalis hired Dr. Martin Birkhofer as senior vice president and chief medical officer;

Lannett promoted Kristie Stephens as vice president of regulatory affairs and chief compliance officer;

Lannett promoted John Kozlowski as corporate controller and vice president, financial operations;

Aequus Pharmaceuticals hired Ann Fehr as chief financial officer;

Pharnext hired Dr. Rene Goedkoop as chief medical officer;

Pharnext hired Francois Chamoun as general counsel;

Pernix Therapeutics named John Sedor as chief executive officer;

Pernix Therapeutics named Graham Miao as president and chief financial officer;

Pernix Therapeutics said Sanjay Patel, chief financial officer; Terence Novak, chief operating officer, and Barry Siegel, senior vice president and general counsel, are no longer with the company.